Loading insider details...
Beta
Latest Form 4 (Mar 2, 2026): Sale of 11,656 OVID shares, $16.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 2, 2026 | Ovid Therapeutics Inc. (OVID) | Sale | 11,656 | $16.9K |
| Jan 5, 2026 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 890,000 | n/a |
| Feb 28, 2025 | Ovid Therapeutics Inc. (OVID) | Sale | 5,279 | $3.0K |
| Feb 25, 2025 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 43,750 | n/a |
| Jan 29, 2025 | Ovid Therapeutics Inc. (OVID) | Purchase | 6,810 | $5.0K |
| Sep 11, 2024 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 140,000 | n/a |